MC
SBCWW

Meteora Capital’s SBC Medical Group Warrants SBCWW Stock Holding History

Meteora Capital’s Portfolio SBCWW Stock Details SBCWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-35,161
Closed -$6.54K – 207
2025
Q1 		$6.54K Sell
35,161
-53,877
-61% -$13K ﹤0.01% 136
2024
Q4 		$21.4K Sell
89,038
-237,962
-73% -$57.4K 0.01% 118
2024
Q3 		$49K Buy
327,000
+225,135
+221% +$23.3K 0.01% 135
2024
Q2 		$7.23K Buy
101,865
+68,060
+201% +$4.96K ﹤0.01% 196
2024
Q1 		$1.02K Hold
33,805
– – ﹤0.01% 255
2023
Q4 		$953 Sell
33,805
-2,095
-6% -$84 ﹤0.01% 297
2023
Q3 		$2.15K Hold
35,900
– – ﹤0.01% 309
2023
Q2 		$2.14K Hold
35,900
– – ﹤0.01% 321
2023
Q1 		$1.7K Hold
35,900
– – ﹤0.01% 381
2022
Q4 		$1.98K Buy
+35,900
New +$1.67K ﹤0.01% 306

Other funds holding SBCWW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Meteora Capital's SBCWW Position: Q2 2025 in Review

Meteora Capital sold out of SBC Medical Group Warrants (SBCWW) in Q2 2025, closing a stake of 35,161 shares — an estimated $6.54K sold.

Meteora Capital first reported a position in SBCWW in Q4 2022 and held it in 10 quarters. The position peaked at $49K in Q3 2024. 18 funds tracked by Wall St. Rank hold SBCWW as of Q2 2025.

  • Meteora Capital reported no remaining SBC Medical Group Warrants position as of Q2 2025 after selling out during the quarter.
  • Meteora Capital sold 35,161 SBC Medical Group Warrants shares in Q2 2025, an estimated $6.54K.
  • Meteora Capital first reported a position in SBC Medical Group Warrants in Q4 2022 and held it in 10 quarters.
  • Meteora Capital's SBC Medical Group Warrants position peaked at $49K in Q3 2024.
  • 18 funds tracked by Wall St. Rank held SBC Medical Group Warrants as of Q2 2025.

Based on Meteora Capital's 13F filing for Q2 2025, filed 14 Aug 2025.